In the current study, we further studied the role of USP13 in NAFLD using USP13 overexpression and knockout techniques after demonstrating reduced USP13 in obese mice and FFA-treated L02 cells. The gene discussed is USP13; the disease is metabolic dysfunction-associated steatotic liver disease.